Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.18
+0.59 (8.95%)
At close: Nov 22, 2024, 4:00 PM
7.17
-0.01 (-0.14%)
After-hours: Nov 22, 2024, 7:55 PM EST
Ginkgo Bioworks Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -651.19 | -892.87 | -2,105 | -1,830 | -126.61 | -119.33 |
| Depreciation & Amortization | 61.25 | 71.55 | 44.42 | 29.08 | 13.86 | 10.76 |
| Loss (Gain) From Sale of Assets | 50.36 | 43.34 | -28.8 | - | - | - |
| Asset Writedown & Restructuring Costs | 77.68 | 130.59 | 1.16 | - | - | - |
| Loss (Gain) From Sale of Investments | 24.78 | 54.83 | 53.34 | 11.54 | 3.73 | 27.2 |
| Loss (Gain) on Equity Investments | 2.64 | 2.64 | 43.76 | 77.28 | 0.4 | 27.53 |
| Stock-Based Compensation | 134.62 | 229.88 | 1,931 | 1,606 | 0.48 | 0.77 |
| Other Operating Activities | 14.68 | 34.7 | -154.79 | -86.16 | -1.18 | -1.26 |
| Change in Accounts Receivable | 22.8 | 50.07 | 55.02 | -114.09 | -14.23 | -1.84 |
| Change in Inventory | - | - | - | - | -2.74 | - |
| Change in Accounts Payable | -27.46 | -1.18 | -10.84 | -2.25 | 7.02 | 0.66 |
| Change in Unearned Revenue | -74.31 | -35.92 | -36.42 | -10.5 | -19.42 | 4.88 |
| Change in Other Net Operating Assets | 29.18 | 16.87 | -44.77 | 65.3 | 2.85 | 6.87 |
| Operating Cash Flow | -334.98 | -295.5 | -252.2 | -253.82 | -135.83 | -44.66 |
| Capital Expenditures | -52.28 | -40.8 | -52.27 | -56.52 | -57.82 | -22.22 |
| Sale of Property, Plant & Equipment | 2.02 | 4.43 | - | - | - | - |
| Cash Acquisitions | -5.4 | - | 74.73 | -12.04 | - | - |
| Divestitures | -42.98 | -42.98 | -55.72 | - | - | - |
| Investment in Securities | 3.95 | - | -3.69 | -5 | - | -50.13 |
| Other Investing Activities | -1.14 | -1.34 | -30.44 | 0.3 | - | - |
| Investing Cash Flow | -95.83 | -80.69 | -67.39 | -73.26 | -67.12 | -74.6 |
| Long-Term Debt Issued | - | - | - | - | - | 199.43 |
| Long-Term Debt Repaid | - | -1.3 | -1.24 | -1.12 | -0.75 | -0.83 |
| Net Debt Issued (Repaid) | -1.01 | -1.3 | -1.24 | -1.12 | -0.75 | 198.61 |
| Issuance of Common Stock | 0.1 | 0.09 | 99.54 | 2,485 | 0.03 | 0.01 |
| Repurchase of Common Stock | -0.02 | -0.02 | -0.98 | -901.71 | - | -0.41 |
| Other Financing Activities | -1.23 | -1.99 | -1.99 | -48.19 | - | - |
| Financing Cash Flow | -2.17 | -3.22 | 95.34 | 1,534 | 90.32 | 410.39 |
| Foreign Exchange Rate Adjustments | -0.11 | -0.59 | 0.91 | -0.02 | - | - |
| Net Cash Flow | -433.08 | -380 | -223.35 | 1,207 | -112.63 | 291.12 |
| Free Cash Flow | -387.26 | -336.3 | -304.47 | -310.34 | -193.65 | -66.88 |
| Free Cash Flow Margin | -177.68% | -133.74% | -63.74% | -98.89% | -252.62% | -123.43% |
| Free Cash Flow Per Share | -7.62 | -6.92 | -7.25 | -9.13 | -6.08 | -2.33 |
| Cash Interest Paid | 0.08 | 0.08 | 0.09 | 2.37 | 2.57 | 2.35 |
| Cash Income Tax Paid | 0.67 | 0.67 | - | 0.06 | - | 0.03 |
| Levered Free Cash Flow | -193.08 | -116.14 | 617.43 | 444.82 | -126.93 | - |
| Unlevered Free Cash Flow | -193.02 | -116.08 | 617.5 | 446.31 | -125.44 | - |
| Change in Net Working Capital | 7.7 | -76.91 | -48.37 | 66.02 | -4.16 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.